Trial Profile
The Effects of Vyvanse on Brain Hemodynamics and Reading.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Feb 2018
Price :
$35
*
At a glance
- Drugs Lisdexamfetamine (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Pharmacodynamics
- Acronyms VBHR
- 07 Apr 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 24 Jun 2009 Planned end date changed from Oct 2008 to Sep 2009 as reported by ClinicalTrials.gov.
- 24 Jun 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.